Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Translate Bio, Inc. | d52920dex322.htm |
| EX-31.2 - EX-31.2 - Translate Bio, Inc. | d52920dex312.htm |
| EX-31.1 - EX-31.1 - Translate Bio, Inc. | d52920dex311.htm |
| EX-10.1 - EX-10.1 - Translate Bio, Inc. | d52920dex101.htm |
| 10-Q - 10-Q - Translate Bio, Inc. | d52920d10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report on Form 10-Q of Translate Bio, Inc. (the “Company”) for the quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), the undersigned, Ronald C. Renaud, Jr., President and Chief Executive Officer, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:
| (1) | The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: November 5, 2020 | By: | /s/ Ronald C. Renaud, Jr. | ||
| Ronald C. Renaud, Jr. President and Chief Executive Officer |
94